Shots: RetinAI signs a multi-year collaboration with Novartis under which RetinAI’s IT solutions and AI tools will be employed to support multiple projects in ophthalmology and digital health The first […]readmore
Tags : Artificial Intelligence
Shots: Deep Genomics will receive an undisclosed upfront payment and is eligible to receive development milestones, BioMarin will receive an exclusive option to obtain Deep Genomics’ rights to each program […]readmore
Medical Affairs is a critical scientific bridge between Healthcare companies and their internal & external stakeholders. It plays a leadership role in implementing cutting-edge medical, scientific, and patient-centered insights & […]readmore
COVID-19 has casted the healthcare community into disarray. Healthcare providers are stressed as the disease has affected more people than the production capacity of healthcare companies to manufacture ventilators, personal […]readmore
Shots: Novartis enters into a 3yrs. collaboration with MILA for transforming the discovery, development & commercialization of therapies by leveraging AI. The collaboration will lead to expansion of the pharmaceutical […]readmore
Shots: Janssen enters into an agreement to utilize Iktos’ AI (in silico drug design) technology for the enhancement of speed & efficacy of its small molecules discovery platform and will […]readmore
Shots: Merck KGaA enters into an agreement with Iktos to develop therapies using Iktos’ AI technology for three drug discovery projects The focus of the agreement is to develop and […]readmore
Shots: FDA grants BT designation to Paige.AI to develop AI in computational pathology for the diagnosis and treatment of cancer including prostate cancer The FDA’s BT designation is granted for […]readmore